Question 1

What is Orano?

Accepted Answer

Orano is a Entity.

Question 2

How often does Orano appear in global news?

Accepted Answer

Tracked across 6 news events drawn from 60 articles.

Question 3

When was Orano first tracked by Ergen?

Accepted Answer

First tracked on Apr 03, 2026.

Question 4

When was Orano last mentioned in news?

Accepted Answer

Last active on Jul 15, 2026.

Question 5

What is Orano's current news sentiment?

Accepted Answer

Aggregate sentiment score: 38 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Orano in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 6 events.

Question 7

What is the most recent event involving Orano?

Accepted Answer

EIB Loans Orano Med 
125M (Jul 01, 2026, 9 articles).

Question 8

How did the "EIB Loans Orano Med 
125M" event impact Orano?

Accepted Answer

Orano's subsidiary, Orano, received a 
125 million loan from the European Investment Bank to advance its nuclear medicine initiatives, particularly in cancer treatment development and industrial infrastructure.

Question 9

How did the "Molecular Partners presents MP0712 data" event impact Orano?

Accepted Answer

Orano is the strategic partner co-developing MP0712 with Molecular Partners, contributing to the advancement of targeted alpha therapy.

Question 10

How did the "Quobly 
00e2
0082
00ac115M Series A Financing" event impact Orano?

Accepted Answer

Orano is a strategic partner of Quobly, leveraging its expertise in process control and yield optimization to support the industrial integration of Quobly's quantum technologies.

Question 11

How did the "Molecular Partners Presents Preclinical Cancer Data" event impact Orano?

Accepted Answer

Orano is co-developing MP0712 with Molecular Partners, and the positive preclinical data could benefit their collaborative efforts.

Question 12

How did the "Molecular Partners presents Radio-DARPins at GRC" event impact Orano?

Accepted Answer

Orano is the co-developer of MP0712, a lead Radio-DARPin candidate in Phase 1/2a trials. The collaboration strengthens its position in targeted alpha therapies.

Question 13

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.